Delivery Order SPE2DB22D1202-SPE2DB24FVBB0
- Not listed
- This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $22,465.18 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of May 31, 2024 and was awarded on May 30, 2024. It is a delivery order contract, with no set-aside designation....
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $16,055.96 firm fixed-price delivery order is for the provision of TALTZ 80 MG/ML autoinjector medication. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,660.30 Firm Fixed Price delivery order is for TALTZ 80 MG/ML AUTOINJECTORML, a medication. The contract is not set aside and has an ultimate completion date of June 26, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,276.32 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024 with a completion date of December 6, 2024. The contract is structured as a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, with a ceiling value of $157,254.66 and a period of performance through March 13, 2025. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $23,597.03 and is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 26, 2025 and is not designated with a set-aside requirement, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,879.90 firm fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a specialty medication. The contract has an ultimate completion date of January 24, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for $6,621.87 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver TALTZ 80 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The contract is a non-set-aside, firm fixed-price delivery order that runs through July 2025. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJ (2-PK)ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $14,822.49 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of July 11, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,508.95 firm fixed-price delivery order is for the supply of TALTZ 80 MG/ML AUTOINJECTORML, a prescription medication. The contract has an ultimate completion date of March 3, 2025 and does not contain any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB24FVBB0Delivery Order
This federal contract award is for the delivery of TALTZ 80 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price valued at $4,188.24. It has an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation, indicating it was made on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/21/24 |